Gainesville, FL – March 2, 2020 – The selection committee at Startup Challenge has chosen Evren Technologies, Inc. to pitch in the final round of the 2020 Startup Challenge North Florida competition in Jacksonville, FL.
Evren Technologies was selected from a large field of quality applicants and will compete with six other top emerging companies for bragging rights as North Florida’s best startup. These seven companies will pitch in front of a panel of esteemed judges with over 50 years of entrepreneurial experience. In addition to the judges’ feedback and expertise, the top company will receive a $10,000 grand prize.
“We are honored to be recognized as one of the top startup companies in North Florida,” said Blythe Karow, President of Evren Technologies. “We are passionate about helping those with PTSD by providing non-invasive, user-friendly solutions and are excited to share our progress.”
The 2020 Startup Challenge North Florida Pitch Competition will take place Thursday, March 12, at the UNF Adam W. Herbert University Center. Companies will present their final pitches from 5:30-8:30 p.m.
This event is the culmination of four months of competition to determine North Florida’s top startup. Tickets can be reserved for free on the Startup Challenge Final Pitch Competition event page on Facebook. (https://www.facebook.com/events/882630858858010/)
About StartUp Challenge: North Florida
The Startup Challenge brings together the brightest minds from across Gainesville, Jacksonville, and more to collaborate and compete for bragging rights as North Florida’s best startup.
Join hundreds of other entrepreneurs in North Florida’s premier pitch competition. Meet other driven individuals, work with experienced mentors, and bring your startup to the spotlight in the Startup Challenge.
About Evren Technologies
Evren Technologies, founded in 2018, is a privately-held medical device company headquartered in Newberry, Florida, near the University of Florida. Evren’s mission is to advance the treatment of PTSD and other psychological disorders through wearable neuromodulation products. The Company’s initial product, the Phoenix™, provides transcutaneous vagal nerve stimulation (tVNS) to treat PTSD in an effective, discreet earbud design.
Comments